Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 273 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1262. Clear
Clear
Q4
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Defense
View →
Q4
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q4
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues
View →
Q4
TWENTY-FIRST CENTURY GROUP, INC. for RAFAEL HOLDINGS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $24,000.00 income
Health Issues
View →
Q4
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate
Pharmacy
View →
Q4
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q4
TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $80,000.00 income
Health Issues
View →
Q4
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q4
MEHLMAN CONSULTING, INC. for ULTRAGENYX PHARMACEUTICAL, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
Q4
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View →
Q4
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q4
THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q4
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q4
LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $30,000.00 income
Health Issues
View →
Q4
LMH STRATEGIC SOLUTIONS for PTC THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $50,000.00 income
Health Issues
View →
Q4
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
Q4
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate
Health Issues
View →
Q4
HOLLAND & KNIGHT LLP for BLACK WOMEN'S HEALTH IMPERATIVE
4th Quarter (Oct 1 - Dec 31) 2025 · Georgia · House · Senate · $20,000.00 income
Health Issues
View →
RR
THE VOGEL GROUP for FORTRESS BIOTECH INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Florida
Health Issues
View →
3A
LUNDBECK LLC for LUNDBECK LLC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Trade (domestic/foreign), Health Issues, Medicare/Medicaid
View →
Q3
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations
View →
Q3
NATIONAL HEALTH COUNCIL for NATIONAL HEALTH COUNCIL
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations
View →
Q3
YC CONSULTING, LLC for PATIENTS RISING NOW
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View →
Q3
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q3
EPILEPSY FOUNDATION for EPILEPSY FOUNDATION
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate
Budget/Appropriations, Health Issues, Civil Rights/Civil Liberties, Education
View →
Previous Page 6 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem